However, it is important to highlight that most of those studies focused on adult patients or on cases with high-risk ALL subtypes, such as Philadelphia chromosome-positive (Ph+) ALL or those harboring IKZF1 (Ikaros) mutations, which may account for the observed discrepancies [23,24,25]. Here, IKZF1 is linked to acute lymphoblastic leukemia.